A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Although treating advanced cancers that affect organs with distant metastasis remains challenging, the pace of recent advances has accelerated; these advances have particularly focused on the inhibitors of key immune potentiates. Research on therapeutic vaccination involving active dendritic cell (DC)-based immunotherapy is also being performed for the induction of an efficient immune response against cancer-associated antigens by the acquired immune system. Cancer vaccines prepared withdoi:10.4172/1745-7580.10000106 fatcat:mearmaqucrdd5l732zz5cq65fe